Viewing Study NCT05096832


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2025-12-25 @ 7:36 PM
Study NCT ID: NCT05096832
Status: COMPLETED
Last Update Posted: 2023-04-25
First Post: 2021-10-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study
Sponsor: Livzon Pharmaceutical Group Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module